{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:31:32Z","timestamp":1791477092276,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32- DK-007245"],"award-info":[{"award-number":["T32- DK-007245"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.eprac.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:20:38Z","timestamp":1765988438000},"page":"392-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Qualitative Study of Clinician Barriers and Facilitators to De-escalation of Thyroid Stimulating Hormone Suppression in Thyroid Cancer Survivors"],"prefix":"10.1016","volume":"32","author":[{"given":"Nina","family":"Francis-Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan R.","family":"Haymart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-0046","authenticated-orcid":false,"given":"Maria","family":"Papaleontiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eprac.2025.12.009_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ecl.2018.10.008","article-title":"Thyroid hormone suppression therapy","volume":"48","author":"Biondi","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"10.1016\/j.eprac.2025.12.009_bib5","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1210\/JC.2015-1346","article-title":"Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987-2012","volume":"100","author":"Carhill","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.12.009_bib6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","article-title":"Outcomes of patients with differentiated thyroid carcinoma following initial therapy","volume":"16","author":"Jonklaas","year":"2006","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.009_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/thy.2024.0330","article-title":"Association between serum thyrotropin and cancer recurrence in differentiated thyroid cancer: a population-based retrospective cohort study","volume":"35","author":"Qiang","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2025.12.009_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.07.057","article-title":"Dose-dependent relationship between levothyroxine and health-related quality of life in survivors of differentiated thyroid cancer","volume":"179","author":"Braafladt","year":"2025","journal-title":"Surgery"},{"key":"10.1016\/j.eprac.2025.12.009_bib9","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae)","year":"2025"},{"issue":"9","key":"10.1016\/j.eprac.2025.12.009_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/thy.2021.0033","article-title":"Thyrotropin suppression for papillary thyroid cancer: a physician survey study","volume":"31","author":"Papaleontiou","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2025.12.009_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102912","article-title":"Thyroid-stimulating hormone suppression in low-risk papillary thyroid cancer: a large-scale retrospective analysis of real-world data","volume":"77","author":"Shi","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.009_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11863","article-title":"Association of thyroid hormone treatment intensity with cardiovascular mortality among US veterans","volume":"5","author":"Evron","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.009_bib13","doi-asserted-by":"crossref","first-page":"e3890","DOI":"10.1210\/clinem\/dgab444","article-title":"Thyroid hormone therapy and incident stroke","volume":"106","author":"Papaleontiou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.009_bib14","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1210\/jc.2017-02629","article-title":"Risk factors for cardiovascular disease among thyroid cancer survivors: findings from the Utah cancer survivors study","volume":"103","author":"Park","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2025.12.009_bib15","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1634\/theoncologist.2019-0234","article-title":"Risk of osteoporosis and fractures in patients with thyroid cancer: a case-control study in U.S. veterans","volume":"24","author":"Papaleontiou","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.eprac.2025.12.009_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/thy.2014.0287","article-title":"Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma","volume":"25","author":"Wang","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eprac.2021.08.007","article-title":"Understanding worry about risks associated with thyroid hormone therapy: a National survey of endocrinologists, family physicians, and geriatricians","volume":"28","author":"Shah","year":"2021","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.surg.2019.04.068","article-title":"Energy level and fatigue after surgery for thyroid cancer: a population-based study of patient-reported outcomes","volume":"167","author":"Hughes","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.eprac.2025.12.009_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamaoto.2020.3260","article-title":"Thyroid cancer clinical guidelines and the De-escalation of care","volume":"146","author":"Haymart","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.009_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health"},{"key":"10.1016\/j.eprac.2025.12.009_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114523","article-title":"Sample sizes for saturation in qualitative research: a systematic review of empirical tests","volume":"292","author":"Hennink","year":"2022","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1525822X16639015","article-title":"How many focus groups are enough? Building an evidence base for nonprobability sample sizes","volume":"29","author":"Guest","year":"2017","journal-title":"Field Methods"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the theoretical domains framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"10.1016\/j.eprac.2025.12.009_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/16094069231183620","article-title":"From data management to actionable findings: a five-phase process of qualitative data analysis","volume":"22","author":"Bingham","year":"2023","journal-title":"Int J Qual Methods"},{"issue":"9","key":"10.1016\/j.eprac.2025.12.009_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.clon.2020.05.015","article-title":"Optimising medications for patients with cancer and multimorbidity: the case for deprescribing","volume":"32","author":"Turner","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.009_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.9375","article-title":"Deprescribing in community-dwelling older adults: a systematic review and meta-analysis","volume":"8","author":"Linsky","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.009_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/jgs.19219","article-title":"Physician-reported barriers and facilitators to thyroid hormone deprescribing in older adults","volume":"73","author":"Moretti","year":"2025","journal-title":"J Am Geriatr Soc"},{"issue":"18","key":"10.1016\/j.eprac.2025.12.009_bib29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.009_bib30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1089\/thy.2020.0679","article-title":"Clinical outcomes after discontinuation of thyroid hormone replacement: a systematic review and meta-analysis","volume":"31","author":"Burgos","year":"2021","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.009_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12020-025-04371-z","article-title":"Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial","volume":"90","author":"Maraka","year":"2025","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.eprac.2025.12.009_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11764-020-00937-0","article-title":"Physician management of thyroid cancer patients\u2019 worry","volume":"15","author":"Papaleontiou","year":"2020","journal-title":"J Cancer Survivorship"},{"issue":"8","key":"10.1016\/j.eprac.2025.12.009_bib33","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1089\/thy.2019.0163","article-title":"Worry in thyroid cancer survivors with a favorable prognosis","volume":"29","author":"Papaleontiou","year":"2019","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.009_bib34","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1002\/hsr2.45","article-title":"Deprescribing medications for older adults in the primary care context: a mixed studies review","volume":"1","author":"Gillespie","year":"2018","journal-title":"Health Sci Rep"},{"issue":"632","key":"10.1016\/j.eprac.2025.12.009_bib35","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.3399\/bjgp15X684001","article-title":"What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care","volume":"65","author":"Sinnott","year":"2015","journal-title":"Br J Gen Pract"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.009_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1370\/afm.2094","article-title":"Swimming against the tide: primary care physicians' views on deprescribing in everyday practice","volume":"15","author":"Wallis","year":"2017","journal-title":"Ann Fam Med"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.009_bib37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: a systematic review","volume":"30","author":"Reeve","year":"2013","journal-title":"Drugs Aging"},{"issue":"9","key":"10.1016\/j.eprac.2025.12.009_bib38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2471\/BLT.21.287654","article-title":"Infodemics and health misinformation: a systematic review of reviews","volume":"100","author":"Borges do Nascimento","year":"2022","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.eprac.2025.12.009_bib40","article-title":"Too much medicine in older people? Deprescribing through shared decision making","volume":"353","author":"Jansen","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib41","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.5688\/ajpe7120","article-title":"A review of the quality indicators of rigor in qualitative research","volume":"84","author":"Johnson","year":"2020","journal-title":"Am J Pharm Educ"},{"issue":"100662","key":"10.1016\/j.eprac.2025.12.009_bib42","first-page":"1","article-title":"How to choose a sampling technique and determine sample size for research: a simplified guide for researchers","volume":"12","author":"Ahmed","year":"2024","journal-title":"Oral Oncol Rep"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.009_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0145482X20987707","article-title":"Convenience sampling revisited: embracing its limitations through thoughtful study design","volume":"115","author":"Emerson","year":"2021","journal-title":"J Vis Impairment Blindness"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.009_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MED.0000000000000758","article-title":"Towards De-Implementation of low-value thyroid care in older adults","volume":"29","author":"Perkins","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:14:22Z","timestamp":1781525662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25013345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1530891X25013345"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.009","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Qualitative Study of Clinician Barriers and Facilitators to De-escalation of Thyroid Stimulating Hormone Suppression in Thyroid Cancer Survivors","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}